A myelin gene causative of a catatonia-depression syndrome upon aging

EMBO Molecular Medicine

Volumn 4, Issue 6, 2012, Pages 528-539

  Hagemeyer, Nora ^a   Goebbels, Sandra ^a   Papiol, Sergi ^a,b   Kästner, Anne ^a   Hofer, Sabine ^c,d   Begemann, Martin ^a   Gerwig, Ulrike C ^a   Boretius, Susann ^b,c   Wieser, Georg L ^a   Ronnenberg, Anja ^a   Gurvich, Artem ^a   Heckers, Stephan H ^e   Frahm, Jens ^b,c,d   Nave, Klaus Armin ^a,b   Ehrenreich, Hannelore ^a,b  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Deutsche Forschungsgemeinschaft   (Germany)

^c Biomedizinische NMR Forschungs GmbH   (Germany)

^d Bernstein Center for Computational Neuroscience (BCCN)   (Germany)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiety; Axonal degeneration; Diffusion tensor imaging; Low grade inflammation; Social withdrawal

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; AMYLOID PRECURSOR PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA;

AGING; ANTERIOR COMMISSURE; ANXIETY; ARTICLE; ASTROCYTOSIS; CATATONIA; CORPUS CALLOSUM; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE CONTROL; EXPLORATORY BEHAVIOR; FEAR; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HUMAN; INFLAMMATION; LOCOMOTION; LOSS OF FUNCTION MUTATION; MAZE TEST; MEMORY; MENTAL DISEASE; MOTOR ACTIVITY; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE STRENGTH; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SMELLING; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TASK PERFORMANCE; WHITE MATTER LESION;

ADULT; AGED; AGING; ANIMALS; BRAIN; CATATONIA; DEPRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROSCOPY; MIDDLE AGED; NEUROIMAGING; PHOSPHORIC DIESTER HYDROLASES;

EID: 84861872484     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201200230     Document Type: Article

References (67)

1. Amir S (1986) Catalepsy induced by body pinch: relation to stress-induced analgesia. Ann N Y Acad Sci 467: 226- 237
2. Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in neurodegenerative diseases. Immunology 129: 154- 169
3. APA. (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, Washington, American Psychiatric Association.
4. Arora M, Praharaj SK (2007) Butterfly glioma of corpus callosum presenting as catatonia. World J Biol Psychiatry 8: 54- 55
5. Aston C, Jiang L Sokolov BP (2005) Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 10: 309- 322
6. Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A Benseler F, et al (2010) Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 67: 879- 888
7. Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld KA, et al (2010) Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 139: 2102- 2112 e2101
8. Berrettini WH (2000) Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 48: 531- 538
9. Bifulco M, Laezza C, Stingo S, Wolff J (2002) 2′, 3′-Cyclic nucleotide 3′-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin. Proc Natl Acad Sci USA 99: 1807- 1812
10. Braun PE, Lee J, Gravel M (2004) 2′, 3′-cyclic nucleotide 3′-phosphodiesterase: structure, biology, and function. In: Myelin Biology and Disorders, Lazzarini RA (ed), San Diego: Elsevier Academic Press pp 499- 522.
11. Brooks SP, Dunnett SB (2009) Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci 10: 519- 529
12. Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13: 243- 281
13. Che R, Tang W, Zhang J, Wei Z, Zhang Z, Huang K, Zhao X, Gao J, Zhou G, Huang P, et al (2009) No relationship between 2′, 3′-cyclic nucleotide 3′-phosphodiesterase and schizophrenia in the Chinese Han population: an expression study and meta-analysis. BMC Med Genet 10: 31
14. Chen EY, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, Hymas NF, Dening TR, Berrios GE (1995) The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res 56: 183- 204
15. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571- 625
16. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60: 443- 456
17. De Angelis DA, Braun PE (1996) 2′, 3′-Cyclic nucleotide 3′-phosphodiesterase binds to actin-based cytoskeletal elements in an isoprenylation-independent manner. J Neurochem 67: 943- 951
18. Derogatis LR, Melisaratos N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13: 595- 605
19. Dumser M, Bauer J, Lassmann H, Berger J, Forss-Petter S (2007) Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency. Acta Neuropathol 114: 573- 586
20. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A, Faichney AB, Snaidero N, Nave KA, Griffiths IR (2009) Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57: 1815- 1824
21. Finn DA, Rutledge-Gorman MT, Crabbe JC (2003) Genetic animal models of anxiety. Neurogenetics 4: 109- 135
22. Gardner A, Boles RG (2011) Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry 35: 730- 743
23. Gravel M, Peterson J, Yong VW, Kottis V, Trapp B Braun PE (1996) Overexpression of 2′, 3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol Cell Neurosci 7: 453- 466
24. Gravel M, Robert F, Kottis V, Gallouzi IE, Pelletier J Braun PE (2009) 2′, 3′-Cyclic nucleotide 3′-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res 87: 1069- 1079
25. Heckers S, Tandon R, Bustillo J (2010) Catatonia in the DSM-shall we move or not? Schizophr Bull 36: 205- 207
26. Hofer S, Frahm J (2006) Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 32: 989- 994
27. Hofer S, Karaus A, Frahm J (2010) Reconstruction and dissection of the entire human visual pathway using diffusion tensor MRI. Front Neuroanat 4: 15
28. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, Wiendl H, Nave KA, Martini R (2006) Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci 26: 8206- 8216
29. Iwamoto K, Ueda J, Bundo M, Nakano Y, Kato T (2008) Effect of a functional single nucleotide polymorphism in the 2′, 3′-cyclic nucleotide 3′-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia. Psychiatry Clin Neurosci 62: 103- 108
30. Jung M, Sommer I, Schachner M, Nave KA (1996) Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16: 7920- 7929
31. Kahlbaum K (1874) Die Katatonie oder das Spannungsirresein., Berlin: Hirschwald
32. Karaus AH S., Frahm J, (2009) Separation of Fiber Tracts within the Human Cingulum Bundle using Single-Shot STEAM DTI. Open Med Imaging J 3: 21- 27
33. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, Werner HB, Natt O, Michaelis T, Prinz M, Frahm J, et al (2007) Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat Genet 39: 969- 976
34. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261- 276
35. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525- 528
36. Kuschinsky K, Hornykiewicz O (1972) Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Eur J Pharmacol 19: 119- 122
37. Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H (2010) Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 71: 520- 527
38. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR Nave KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366- 374
39. Lee J, Gravel M, Zhang R, Thibault P, Braun PE (2005) Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 170: 661- 673
40. Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3: 457- 465
41. Miller KR, Streit WJ (2007) The effects of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol 3: 245- 253
42. Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE, Lipska BK (2008) Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Schizophr Res 98: 129- 138
43. Monji A, Kato T, Kanba S (2009) Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63: 257- 265
44. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47- 60
45. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN (2004) Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 3: 287- 302
46. Muller N, Schwarz MJ (2008) A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci 258: 97- 106
47. Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, Moller HJ, Klauss V, Schwarz MJ, Riedel M (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res 121: 118- 124
48. Nielsen KB, Sorensen S, Cartegni L, Corydon TJ, Doktor TK, Schroeder LD, Reinert LS, Elpeleg O, Krainer AR, Gregersen N, et al (2007) Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80: 416- 432
49. Northoff G, Kotter R, Baumgart F, Danos P, Boeker H, Kaulisch T, Schlagenhauf F, Walter H, Heinzel A, Witzel T, et al (2004) Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull 30: 405- 427
50. Norton WT, Poduslo SE (1973) Myelination in rat brain: method of myelin isolation. J Neurochem 21: 749- 757
51. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, et al (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053- 1055
52. Peirce TR, Bray NJ, Williams NM, Norton N, Moskvina V, Preece A, Haroutunian V, Buxbaum JD, Owen MJ, O'Donovan MC (2006) Convergent evidence for 2′, 3′-cyclic nucleotide 3′-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry 63: 18- 24
53. Radyushkin K, Hammerschmidt K, Boretius S, Varoqueaux F, El-Kordi A, Ronnenberg A, Winter D, Frahm J, Fischer J, Brose N, et al (2009) Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 8: 416- 425
54. Radyushkin K, El-Kordi A, Boretius S, Castaneda S, Ronnenberg A, Reim K, Bickeboller H, Frahm J, Brose N, Ehrenreich H (2010) Complexin2 null mutation requires a 'second hit' for induction of phenotypic changes relevant to schizophrenia. Genes Brain Behav 9: 592- 602
55. Ribbe K, Friedrichs H, Begemann M, Grube S, Papiol S, Kastner A, Gerchen MF, Ackermann V, Tarami A, Treitz A, et al (2010) The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 10: 91
56. Scherer SS, Braun PE, Grinspan J, Collarini E, Wang DY, Kamholz J (1994) Differential regulation of the 2′, 3′-cyclic nucleotide 3′-phosphodiesterase gene during oligodendrocyte development. Neuron 12: 1363- 1375
57. Schnieder TP, Dwork AJ (2011) Searching for neuropathology: gliosis in schizophrenia. Biol Psychiatry 69: 134- 139
58. Sham PC, Jones P, Russell A, Gilvarry K, Bebbington P, Lewis S, Toone B, Murray R (1994) Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 165: 466- 473
59. Smith KJ, Lassmann H (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol 1: 232- 241
60. Sparkman NL, Johnson RW (2008) Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation 15: 323- 330
61. Starkstein SE, Petracca G, Teson A, Chemerinski E, Merello M, Migliorelli R, Leiguarda R (1996) Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry 60: 326- 332
62. Stone EA, Lin Y (2011) Open-space forced swim model of depression for mice. Curr Protoc Neurosci 9: 36
63. Streit WJ (2006) Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci 29: 506- 510
64. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798- 805
65. Valles V, Van Os J, Guillamat R, Gutierrez B, Campillo M, Gento P, Fananas L (2000) Increased morbid risk for schizophrenia in families of in-patients with bipolar illness. Schizophr Res 42: 83- 90
66. Yin X, Peterson J, Gravel M, Braun PE, Trapp BD (1997) CNP overexpression induces aberrant oligodendrocyte membranes and inhibits MBP accumulation and myelin compaction. J Neurosci Res 50: 238- 247
67. Yu WP, Collarini EJ, Pringle NP, Richardson WD (1994) Embryonic expression of myelin genes: evidence for a focal source of oligodendrocyte precursors in the ventricular zone of the neural tube. Neuron 12: 1353- 1362